Medical AI Regulation Sparks Intense Lobbying Battle Across States

October 14, 2026 - 16:26

Lobbying groups representing doctors, hospitals, and major industry players are quietly working to influence how individual states write rules for artificial intelligence in medicine. The fight is playing out in statehouses across the country, where lawmakers are considering dozens of bills that would set standards for AI tools used in diagnosis, treatment planning, and patient care.

Physician organizations want a strong say in how these systems get approved and monitored. They argue that doctors should remain in the loop for critical decisions and that AI should not replace clinical judgment. Hospital associations, meanwhile, are pushing for flexibility so they can adopt new technology without drowning in red tape.

Trade groups backed by tech companies and AI developers are taking a different approach. They warn that a patchwork of strict state laws could slow innovation and create confusion for companies trying to operate nationwide. Some are urging lawmakers to wait for federal guidance instead of acting on their own.

Patient advocacy groups have also entered the debate, calling for transparency about how AI tools make recommendations and who is accountable when something goes wrong. With so much money and influence at stake, the outcome of these state-level battles could shape how quickly and safely AI becomes part of everyday medical care.